Pitt Street Research

InvitroCue

InvitroCue

Invitrocue (ASX:IVQ)

Invitrocue is leveraging its expertise in 3D cell culture to grow ‘Patient-Derived Organoids’ against which a range of cancer therapies can be tested. With Onco-PDO, the way is open for low-cost personalised cancer medicine, where the market opportunity lies in the billions.